Moneycontrol PRO
you are here: HomeNewsTrendsHealth

Dip in average daily vaccination against COVID-19 since June 21, govt data shows

According to data available on CoWIN platform, an average of 61.14 lakh doses of COVID-19 vaccine were administered daily in the week from June 21-27 which dropped to 41.92 lakh doses daily in the subsequent week from June 28-July 4.

July 12, 2021 / 02:00 PM IST

A decline in average daily vaccination against the coronavirus has been seen since June 21, when the new phase of universalisation of COVID-19 vaccination commenced, government data showed.

According to data available on CoWIN platform, an average of 61.14 lakh doses of COVID-19 vaccine were administered daily in the week from June 21-27 which dropped to 41.92 lakh doses daily in the subsequent week from June 28-July 4.

In the week from July 5 to July 11, the daily average vaccine doses number further dipped to 34.32 lakh doses.

Follow our LIVE blog for latest updates of the novel coronavirus pandemic

Among states, however, a mixed trend has emerged with some states and UTs reporting a sinusoidal trend of vaccination while others a dip.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

States such as Haryana, Andhra Pradesh, Karnataka, Gujarat and Chhattisgarh showed a decline in average daily vaccinations since the week of June 21-27 while a sinusoidal trend in administration of daily doses of COVID-19 was seen in states and UTs like Kerala, Andaman and Nicobar Islands, Dadra and Nagar Haveli, Jammu and Kashmir, according to CoWIN data.

In the states of  Assam and Tripura which recently reported a rise in fresh COVID-19 cases, a declining trend in administration of average daily vaccine doses can be seen.

Even then the daily average vaccination remained higher than the previous phase of COVID-19 vaccination.

In the week from June 14-20, just 33.97 lakh doses of COVID-19 vaccine were administered daily on an average.

On Monday, the Health Ministry said over 1.54 crore balance and unutilised COVID-19 vaccine doses are still available with the states, UTs and private hospitals to be administered.

The cumulative vaccine doses administered so far has reached 37.73 crore under the Nationwide Vaccination Drive.

Follow our full coverage of the coronavirus pandemic here.
PTI
first published: Jul 12, 2021 01:59 pm
Sections
ISO 27001 - BSI Assurance Mark